A proposed rule (pdf) would focus on reducing costs through several regulations:
• Alignment of reimbursement rates that reflect the actual price the pharmacy pays for the prescription drug.
• An increase in rebates paid by drug manufacturers that participate in Medicaid.
• Drug rebates for Medicaid beneficiaries who are in a Medicaid managed care organization.
The proposed rule will be published in the Federal Register on Feb. 2, and comments can be submitted through April 2.
Related Articles on Prescription Drugs:
National Council for Prescription Drug Programs Announces 2011 Accomplishments
CVS Agrees to $5M Settlement with FTC
OIG: CMS Accepted $15.1M in Prescriptions Written by Excluded Providers
